Cargando…

A revised compartmental model for biokinetics and dosimetry of 2-[(18)F]FDG

BACKGROUND: The aim was to review available biokinetic data, collect own experimental data, and propose an updated compartmental model for 2-[(18)F]FDG in the frame of the revision of the ICRP report on dose coefficients for radiopharmaceuticals used in diagnostic nuclear medicine. METHODS: The comp...

Descripción completa

Detalles Bibliográficos
Autores principales: Kamp, Alexandra, Andersson, Martin, Leide-Svegborn, Sigrid, Noβke, Dietmar, Mattsson, Sören, Giussani, Augusto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9908780/
https://www.ncbi.nlm.nih.gov/pubmed/36752876
http://dx.doi.org/10.1186/s40658-023-00528-9
_version_ 1784884435625181184
author Kamp, Alexandra
Andersson, Martin
Leide-Svegborn, Sigrid
Noβke, Dietmar
Mattsson, Sören
Giussani, Augusto
author_facet Kamp, Alexandra
Andersson, Martin
Leide-Svegborn, Sigrid
Noβke, Dietmar
Mattsson, Sören
Giussani, Augusto
author_sort Kamp, Alexandra
collection PubMed
description BACKGROUND: The aim was to review available biokinetic data, collect own experimental data, and propose an updated compartmental model for 2-[(18)F]FDG in the frame of the revision of the ICRP report on dose coefficients for radiopharmaceuticals used in diagnostic nuclear medicine. METHODS: The compartmental model was developed based on published biokinetic data for 2-[(18)F]FDG. Additional data on urinary excretion in 23 patients (11 males, 12 females) undergoing whole-body PET/CT examinations were obtained within this study. The unknown biokinetic model parameters were derived using the software SAAM II and verified with a modified version of IDAC-Iodide. Dose coefficients for reference adults were calculated with the programme IDAC-Dose 2.1. A dynamic bladder model was employed for urinary bladder dosimetry. RESULTS: The proposed model consists of following compartments: blood, heart wall, brain, liver, lungs, pancreas, spleen, kidneys, urinary bladder content and a generic pool compartment “Other”. The latter was introduced to account for 2-[(18)F]FDG in body organ and tissues besides the explicitly modelled ones. The model predictions showed a good agreement with experimental data. Urinary bladder wall received the highest absorbed dose coefficient of 7.5E−02 mGy/MBq under the assumption of initial urine volume of 100 ml, first voiding at 45 min p.i. and 3.75 h voiding intervals thereafter. The effective dose coefficient calculated according to the current dosimetry framework of ICRP amounted to 1.7E−02 mSv/MBq, compared to 1.9E−02 mSv/MBq in ICRP Publication 128. CONCLUSION: A compartmental model for 2-[(18)F]FDG was proposed and will be used to replace the descriptive biokinetic model of ICRP Publication 128. The revised model and the provided dose coefficients are expected to improve reference dosimetry for patients administered with 2-[(18)F]FDG. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40658-023-00528-9.
format Online
Article
Text
id pubmed-9908780
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-99087802023-02-10 A revised compartmental model for biokinetics and dosimetry of 2-[(18)F]FDG Kamp, Alexandra Andersson, Martin Leide-Svegborn, Sigrid Noβke, Dietmar Mattsson, Sören Giussani, Augusto EJNMMI Phys Original Research BACKGROUND: The aim was to review available biokinetic data, collect own experimental data, and propose an updated compartmental model for 2-[(18)F]FDG in the frame of the revision of the ICRP report on dose coefficients for radiopharmaceuticals used in diagnostic nuclear medicine. METHODS: The compartmental model was developed based on published biokinetic data for 2-[(18)F]FDG. Additional data on urinary excretion in 23 patients (11 males, 12 females) undergoing whole-body PET/CT examinations were obtained within this study. The unknown biokinetic model parameters were derived using the software SAAM II and verified with a modified version of IDAC-Iodide. Dose coefficients for reference adults were calculated with the programme IDAC-Dose 2.1. A dynamic bladder model was employed for urinary bladder dosimetry. RESULTS: The proposed model consists of following compartments: blood, heart wall, brain, liver, lungs, pancreas, spleen, kidneys, urinary bladder content and a generic pool compartment “Other”. The latter was introduced to account for 2-[(18)F]FDG in body organ and tissues besides the explicitly modelled ones. The model predictions showed a good agreement with experimental data. Urinary bladder wall received the highest absorbed dose coefficient of 7.5E−02 mGy/MBq under the assumption of initial urine volume of 100 ml, first voiding at 45 min p.i. and 3.75 h voiding intervals thereafter. The effective dose coefficient calculated according to the current dosimetry framework of ICRP amounted to 1.7E−02 mSv/MBq, compared to 1.9E−02 mSv/MBq in ICRP Publication 128. CONCLUSION: A compartmental model for 2-[(18)F]FDG was proposed and will be used to replace the descriptive biokinetic model of ICRP Publication 128. The revised model and the provided dose coefficients are expected to improve reference dosimetry for patients administered with 2-[(18)F]FDG. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40658-023-00528-9. Springer International Publishing 2023-02-08 /pmc/articles/PMC9908780/ /pubmed/36752876 http://dx.doi.org/10.1186/s40658-023-00528-9 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Research
Kamp, Alexandra
Andersson, Martin
Leide-Svegborn, Sigrid
Noβke, Dietmar
Mattsson, Sören
Giussani, Augusto
A revised compartmental model for biokinetics and dosimetry of 2-[(18)F]FDG
title A revised compartmental model for biokinetics and dosimetry of 2-[(18)F]FDG
title_full A revised compartmental model for biokinetics and dosimetry of 2-[(18)F]FDG
title_fullStr A revised compartmental model for biokinetics and dosimetry of 2-[(18)F]FDG
title_full_unstemmed A revised compartmental model for biokinetics and dosimetry of 2-[(18)F]FDG
title_short A revised compartmental model for biokinetics and dosimetry of 2-[(18)F]FDG
title_sort revised compartmental model for biokinetics and dosimetry of 2-[(18)f]fdg
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9908780/
https://www.ncbi.nlm.nih.gov/pubmed/36752876
http://dx.doi.org/10.1186/s40658-023-00528-9
work_keys_str_mv AT kampalexandra arevisedcompartmentalmodelforbiokineticsanddosimetryof218ffdg
AT anderssonmartin arevisedcompartmentalmodelforbiokineticsanddosimetryof218ffdg
AT leidesvegbornsigrid arevisedcompartmentalmodelforbiokineticsanddosimetryof218ffdg
AT nobkedietmar arevisedcompartmentalmodelforbiokineticsanddosimetryof218ffdg
AT mattssonsoren arevisedcompartmentalmodelforbiokineticsanddosimetryof218ffdg
AT giussaniaugusto arevisedcompartmentalmodelforbiokineticsanddosimetryof218ffdg
AT kampalexandra revisedcompartmentalmodelforbiokineticsanddosimetryof218ffdg
AT anderssonmartin revisedcompartmentalmodelforbiokineticsanddosimetryof218ffdg
AT leidesvegbornsigrid revisedcompartmentalmodelforbiokineticsanddosimetryof218ffdg
AT nobkedietmar revisedcompartmentalmodelforbiokineticsanddosimetryof218ffdg
AT mattssonsoren revisedcompartmentalmodelforbiokineticsanddosimetryof218ffdg
AT giussaniaugusto revisedcompartmentalmodelforbiokineticsanddosimetryof218ffdg